Pharmaceutical firm Danco Labs allegedly imported products lacking country-of-origin labels from China yet failed to pay the 10% marking duties it owed.
Drug distributor Danco Laboratories has agreed to pay $765,000 to resolve a federal whistleblower lawsuit alleging it violated the False Claims Act by failing to pay marking duties on products it imported from China without country-of-origin labels.
Imports are required to be labeled with their “country of origin,” meaning the country where the product was manufactured or produced or where work was performed resulting in its “substantial transformation” into the finished article.